Xlumena closes Series C financing
Xlumena has closed a $25 million Series C financing. Led by Third Point, the round of funding includes existing investors Prism VentureWorks, Charter Life Sciences, Ascent Biomedical Ventures and Aperture Venture Partners.
3 December 2013•2 mins read
